Published in Mol Cell Proteomics on November 04, 2015
Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Oncotarget (2016) 0.79
Quantitative investigation of human cell surface N-glycoprotein dynamics. Chem Sci (2016) 0.77
Affinity purification of erythropoietin from cell culture supernatant combined with MALDI-TOF-MS analysis of erythropoietin N-glycosylation. Sci Rep (2017) 0.75
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov (2012) 26.98
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal (2013) 19.54
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Evaluating cell lines as tumour models by comparison of genomic profiles. Nat Commun (2013) 4.35
Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology (2009) 2.87
Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (1976) 2.65
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci (2004) 2.31
Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A (2010) 2.22
Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res (1976) 1.97
Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor. J Natl Cancer Inst (1975) 1.91
The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther (2004) 1.90
Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci U S A (2005) 1.78
Glycans as cancer biomarkers. Biochim Biophys Acta (2011) 1.66
Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci (2008) 1.63
Cancer cell lines for drug discovery and development. Cancer Res (2014) 1.60
Pathway-specific differences between tumor cell lines and normal and tumor tissue cells. Mol Cancer (2006) 1.51
Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines. Proc Natl Acad Sci U S A (2004) 1.27
High-throughput profiling of protein N-glycosylation by MALDI-TOF-MS employing linkage-specific sialic acid esterification. Anal Chem (2014) 1.27
Fucosylation and gastrointestinal cancer. World J Hepatol (2010) 1.25
Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Anal Chem (2011) 1.24
Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1. Proc Natl Acad Sci U S A (2009) 1.20
Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers (2008) 1.20
Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis (2012) 1.19
Approach for defining endogenous reference genes in gene expression experiments. Anal Biochem (2004) 1.14
A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J Proteome Res (2009) 1.12
N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Mol Cell Proteomics (2012) 1.11
Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells. Mol Cell Proteomics (2011) 1.11
Mass spectrometric glycan rearrangements. Mass Spectrom Rev (2011) 1.07
DLD-1 and HCT-15 cell lines derived separately from colorectal carcinomas have totally different chromosome changes but the same genetic origin. Cancer Genet Cytogenet (1995) 1.04
2-picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics (2010) 1.02
Fucosylation is a promising target for cancer diagnosis and therapy. Biomolecules (2012) 1.02
In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. Br J Cancer Suppl (1980) 1.01
Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem (2013) 1.01
A novel lectin from Agrocybe aegerita shows high binding selectivity for terminal N-acetylglucosamine. Biochem J (2012) 0.96
Glycosylation characteristics of colorectal cancer. Adv Cancer Res (2015) 0.95
Activation of human endothelial cells by tumor necrosis factor-alpha results in profound changes in the expression of glycosylation-related genes. J Cell Physiol (2006) 0.94
Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. J Proteome Res (2013) 0.92
Gene expression analysis of glycosylation-related genes by real-time polymerase chain reaction. Methods Mol Biol (2006) 0.88
MassyTools: A High-Throughput Targeted Data Processing Tool for Relative Quantitation and Quality Control Developed for Glycomic and Glycoproteomic MALDI-MS. J Proteome Res (2015) 0.87
Intercellular karyotypic similarity in near-diploid cell lines of human tumor origins. Cancer Genet Cytogenet (1983) 0.87
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. Glycobiology (2007) 0.87
Villin expression is frequently lost in poorly differentiated colon cancer. Am J Pathol (2012) 0.86
Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies. J Proteomics (2014) 0.86
Fucosylated TGF-β receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br J Cancer (2013) 0.86
B4GALNT2 gene expression controls the biosynthesis of Sda and sialyl Lewis X antigens in healthy and cancer human gastrointestinal tract. Int J Biochem Cell Biol (2014) 0.85
N-glycomic profiling as a tool to separate rectal adenomas from carcinomas. Mol Cell Proteomics (2014) 0.83
A cost-effective plate-based sample preparation for antibody N-glycan analysis. J Chromatogr A (2013) 0.82
Rapid analysis of cell surface N-glycosylation from living cells using mass spectrometry. J Proteome Res (2014) 0.82
UDP-GalNAc:NeuAc alpha 2,3Gal beta-R (GalNAc to Gal) beta 1,4-N-acetylgalactosaminyltransferase responsible for the Sda specificity in human colon carcinoma CaCo-2 cell line. Biochem Biophys Res Commun (1991) 0.81
Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling. J Proteome Res (2014) 0.81
β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer. Carcinogenesis (2014) 0.81
N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells. J Cell Biochem (2012) 0.81
Highly fucosylated N-glycan ligands for mannan-binding protein expressed specifically on CD26 (DPPVI) isolated from a human colorectal carcinoma cell line, SW1116. Glycobiology (2009) 0.80
Primary cell lines: false representation or model system? a comparison of four human colorectal tumors and their coordinately established cell lines. Int J Clin Exp Med (2010) 0.80
Highly glycosylated tumour antigens: interactions with the immune system. Biochem Soc Trans (2011) 0.78
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics (2015) 0.88